Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
ALKS 9072, High dose
DRUG
2 trials
Sponsors
Alkermes, Inc.
Conditions
Schizophrenia
Phase 1
A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia
Completed
NCT01493726
Alkermes, Inc.
Schizophrenia
Start: 2011-12-31
End: 2013-06-30
Updated: 2018-08-29
Phase 3
An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)
Completed
NCT01895452
Alkermes, Inc.
Schizophrenia
Start: 2013-07-31
End: 2016-06-30
Updated: 2017-08-25
Related Papers
Long-term effect of aripiprazole lauroxil on health-related quality of life in patients with schizophrenia.
2021-03-24
6 citations
Beyond 52-Week Long-Term Safety
The Journal of Clinical Psychiatry
2020-08-17
4 citations
63 Long-term Outcomes with Aripiprazole Lauroxil for the Treatment of Schizophrenia: A 2-Year, Phase 3, Multicenter Extension Study
CNS Spectrums
2019-02-01
1 citations